Literature DB >> 23137521

Outbreak of measles in Central and Eastern Cheshire, UK, October 2008-February 2009.

S Ghebrehewet1, G Hayhurst, A Keenan, H Moore.   

Abstract

We describe the largest outbreak of measles in Central and Eastern Cheshire (North West England) since the MMR vaccine was introduced in 1988, the majority of cases were not vaccinated and more than 20% of the cases belonged to the travelling community. Over 4 months,147 clinical cases of measles were notified locally to the Cheshire & Merseyside Health Protection Unit (CMHPU). Of these, 67 (45.6%) were laboratory confirmed, 42 (28.6%) were negative, and one was equivocal, leaving 23 probable and 14 possible cases. The primary case was probably an 8-year-old unvaccinated travelling child, symptomatic on 1 October 2008. Measles spread locally and within school-aged children until early February 2009. Most of Central and Eastern Cheshire, including 23 educational institutions (playgroups, nurseries, primary schools, secondary schools, colleges), were affected, showing that there were enough susceptible/unvaccinated children to sustain an outbreak. Nearly a quarter of the confirmed cases (15/67, 22.4%) were aged <13 months and too young to be vaccinated under the UK immunization schedule. This outbreak is a reminder of the importance of achieving herd immunity to prevent spread and protect those at risk of severe illness or complications. There were no fatalities in this outbreak and no significant complications were reported.

Entities:  

Mesh:

Year:  2012        PMID: 23137521      PMCID: PMC9151405          DOI: 10.1017/S0950268812002300

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  14 in total

1.  MMR and autism: further evidence against a causal association.

Authors:  C P Farrington; E Miller; B Taylor
Journal:  Vaccine       Date:  2001-06-14       Impact factor: 3.641

2.  The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989.

Authors:  C Miller; C P Farrington; K Harbert
Journal:  Int J Epidemiol       Date:  1992-10       Impact factor: 7.196

3.  Lessons from an online debate about measles-mumps-rubella (MMR) immunization.

Authors:  Michelle S Nicholson; Julie Leask
Journal:  Vaccine       Date:  2011-11-07       Impact factor: 3.641

4.  Measles in Europe: an epidemiological assessment.

Authors:  Mark Muscat; Henrik Bang; Jan Wohlfahrt; Steffen Glismann; Kåre Mølbak
Journal:  Lancet       Date:  2009-01-07       Impact factor: 79.321

5.  Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age.

Authors:  J Klinge; S Lugauer; K Korn; U Heininger; K Stehr
Journal:  Vaccine       Date:  2000-07-15       Impact factor: 3.641

Review 6.  Clinical spectrum of measles.

Authors:  M Katz
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

7.  Traveller Gypsies and childhood immunization: a study in east London.

Authors:  G S Feder; T Vaclavik; A Streetly
Journal:  Br J Gen Pract       Date:  1993-07       Impact factor: 5.386

8.  Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.

Authors:  Brent Taylor; Elizabeth Miller; Raghu Lingam; Nick Andrews; Andrea Simmons; Julia Stowe
Journal:  BMJ       Date:  2002-02-16

9.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

Authors:  A J Wakefield; S H Murch; A Anthony; J Linnell; D M Casson; M Malik; M Berelowitz; A P Dhillon; M A Thomson; P Harvey; A Valentine; S E Davies; J A Walker-Smith
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

10.  The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.

Authors:  C Miller; N Andrews; M Rush; H Munro; L Jin; E Miller
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

View more
  6 in total

Review 1.  Antibiotics for preventing complications in children with measles.

Authors:  Sushil K Kabra; Rakesh Lodha
Journal:  Cochrane Database Syst Rev       Date:  2013-08-14

Review 2.  Evolving measles status and immunization policy development in six European countries.

Authors:  Ivo Vojtek; Heidi Larson; Stanley Plotkin; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2022-02-18       Impact factor: 4.526

3.  Addressing the Vaccine Hesitancy Continuum: An Audience Segmentation Analysis of American Adults Who Did Not Receive the 2009 H1N1 Vaccine.

Authors:  Shoba Ramanadhan; Ezequiel Galarce; Ziming Xuan; Jaclyn Alexander-Molloy; Kasisomayajula Viswanath
Journal:  Vaccines (Basel)       Date:  2015-07-15

Review 4.  Adverse events of vaccines and the consequences of non-vaccination: a critical review.

Authors:  Luana Raposo de Melo Moraes Aps; Marco Aurélio Floriano Piantola; Sara Araujo Pereira; Julia Tavares de Castro; Fernanda Ayane de Oliveira Santos; Luís Carlos de Souza Ferreira
Journal:  Rev Saude Publica       Date:  2018-04-12       Impact factor: 2.106

5.  The effect of measles on health-related quality of life: a patient-based survey.

Authors:  Dominic Thorrington; Mary Ramsay; Albert Jan van Hoek; W John Edmunds; Roberto Vivancos; Antoaneta Bukasa; Ken Eames
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

6.  Assessment of the Utility of Whole Genome Sequencing of Measles Virus in the Characterisation of Outbreaks.

Authors:  Ana Raquel Penedos; Richard Myers; Besma Hadef; Farah Aladin; Kevin E Brown
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.